Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (71-80 of 320) with videos related to

Pageof 32
Sort By:
BMC Gastroenterology|January 19, 2023
Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countriesAlessandro Armuzzi, Ailsa Hart, Joseph C Cappelleri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 24, 2023
Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodologyStefanos Bonovas, Daniele Piovani, Claudia Pansieri, et al.
Eclinicalmedicine|October 23, 2025
Variability and performance of radiologic stricture parameters in Crohn's disease: a systematic review and meta-analysisArianna Dal Buono, Francesco Faita, Sarah Bencardino, et al.
Expert Opinion on Biological Therapy|May 21, 2025
The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilarJae Hee Cheon, Byong Duk Ye, Alessandro Armuzzi, et al.
Pathology, Research and Practice|September 9, 2020
Microscopic imaging of Inflammatory Bowel Disease (IBD) and Non-IBD Colitis on digital slides: The Italian Group-IBD Pathologists experienceTiziana Salviato, Luca Reggiani Bonetti, Alessandro Mangogna, et al.
Inflammatory Bowel Diseases|January 29, 2021
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS SurveyDavid T Rubin, Charles Sninsky, Britta Siegmund, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 5, 2023
Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world settingLuca Degli Esposti, Valentina Perrone, Diego Sangiorgi, et al.
Frontiers in Immunology|July 30, 2025
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammationGiulia Migliorisi, Roberto Gabbiadini, Arianna Dal Buono, et al.
Journal of Clinical Medicine|July 13, 2024
Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian SurveyCristiana Bonifacio, Arianna Dal Buono, Riccardo Levi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 20, 2022
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodologyStefanos Bonovas, Claudia Pansieri, Daniele Piovani, et al.
Pageof 32

Showing results (71-80 of 320) with videos related to

Sort By:
Pageof 32
BMC Gastroenterology|January 19, 2023
Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countriesAlessandro Armuzzi, Ailsa Hart, Joseph C Cappelleri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 24, 2023
Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodologyStefanos Bonovas, Daniele Piovani, Claudia Pansieri, et al.
Eclinicalmedicine|October 23, 2025
Variability and performance of radiologic stricture parameters in Crohn's disease: a systematic review and meta-analysisArianna Dal Buono, Francesco Faita, Sarah Bencardino, et al.
Expert Opinion on Biological Therapy|May 21, 2025
The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilarJae Hee Cheon, Byong Duk Ye, Alessandro Armuzzi, et al.
Pathology, Research and Practice|September 9, 2020
Microscopic imaging of Inflammatory Bowel Disease (IBD) and Non-IBD Colitis on digital slides: The Italian Group-IBD Pathologists experienceTiziana Salviato, Luca Reggiani Bonetti, Alessandro Mangogna, et al.
Inflammatory Bowel Diseases|January 29, 2021
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS SurveyDavid T Rubin, Charles Sninsky, Britta Siegmund, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 5, 2023
Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world settingLuca Degli Esposti, Valentina Perrone, Diego Sangiorgi, et al.
Frontiers in Immunology|July 30, 2025
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammationGiulia Migliorisi, Roberto Gabbiadini, Arianna Dal Buono, et al.
Journal of Clinical Medicine|July 13, 2024
Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian SurveyCristiana Bonifacio, Arianna Dal Buono, Riccardo Levi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 20, 2022
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodologyStefanos Bonovas, Claudia Pansieri, Daniele Piovani, et al.
Pageof 32